Related Experiment Videos
Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug
Franciska Piccolo1, Giacomo Bagni2, Annarosa Arcangeli3
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Abstract:
Triple-negative breast cancer (TNBC) represents a highly aggressive and therapeutically challenging subtype of breast cancer, characterized by the absence of estrogen receptor, progesterone receptor and HER2 expression. Recent advances in transcriptomics have highlighted the pivotal role of long non-coding RNAs (lncRNAs) in the regulation of gene expression, tumor progression and therapeutic resistance in TNBC. This review synthesizes current knowledge on the functional mechanisms of lncRNAs in TNBC, including their involvement in epithelial-mesenchymal transition, immune modulation and metabolic reprogramming. We discuss key lncRNAs implicated in TNBC pathogenesis and their potential as diagnostic biomarkers, prognostic indicators and therapeutic targets. By elucidating the complex interplay between lncRNAs and oncogenic pathways, this review underscores the promise of lncRNA-based strategies in improving TNBC management and patient outcomes.
Insights
Long non-coding RNAs (lncRNAs) are crucial in regulating triple-negative breast cancer (TNBC) aggressiveness and treatment resistance. Understanding lncRNA functions offers new diagnostic and therapeutic avenues for this challenging cancer subtype.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype lacking standard therapeutic targets.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their regulatory roles in cancer.
Purpose of the Study:
- To review the functional mechanisms of lncRNAs in TNBC pathogenesis.
- To highlight lncRNAs as potential biomarkers and therapeutic targets for TNBC.
Main Methods:
- Literature review synthesizing current knowledge on lncRNAs in TNBC.
- Analysis of lncRNA involvement in key cancer processes like EMT, immune modulation, and metabolism.
Main Results:
- lncRNAs play significant roles in TNBC progression, influencing epithelial-mesenchymal transition (EMT), immune evasion, and metabolic reprogramming.
- Specific lncRNAs are implicated in TNBC development and can serve as diagnostic/prognostic markers.
Conclusions:
- lncRNA-based strategies hold promise for improving TNBC diagnosis, prognosis, and treatment.
- Further research into lncRNA-oncogene interactions is essential for advancing TNBC management.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
The Nucleolus
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
MicroRNAs